139356-37-9

Basic information

• Product Name: 2-((3R,5R)-3,5-bis(tert-butyldiMethylsilyloxy)cyclohexylidene)ethanol
• Synonyms: 2-((3R,5R)-3,5-bis(tert-butyldiMethylsilyloxy)cyclohexylidene)ethanol;(Z)-2-((3R,5R)-3-((tert-butyldiMethylsilyl)oxy)-5-((isopropyldiMethylsilyl)oxy)cyclohexylidene)ethanol;2-[(3R,5R)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]cyclohexylidene]ethanol;Ethanol, 2-[(3R,5R)-3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]cyclohexylidene]-;2-((3R,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)cyclohexylidene)ethan-1-ol
• CAS NO: 139356-37-9
• Molecular Formula: C₂₀H₄₂O₃Si₂
• Molecular Weight: 386.71668
• Mol File: 139356-37-9.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-((3R,5R)-3,5-bis(tert-butyldiMethylsilyloxy)cyclohexylidene)ethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-((3R,5R)-3,5-bis(tert-butyldiMethylsilyloxy)cyclohexylidene)ethanol(139356-37-9)
• EPA Substance Registry System: 2-((3R,5R)-3,5-bis(tert-butyldiMethylsilyloxy)cyclohexylidene)ethanol(139356-37-9)

Safety Data

• Hazardous Substances Data: 139356-37-9(Hazardous Substances Data)

Usage

General Description

2-((3R,5R)-3,5-bis(tert-butyldimethylsilyloxy)cyclohexylidene)ethanol is a chemical compound with the molecular formula C20H42O3Si2. It is a derivative of cyclohexylidene ethanol and contains two tert-butyldimethylsilyloxy groups attached to the cyclohexylidene ring. 2-((3R,5R)-3,5-bis(tert-butyldiMethylsilyloxy)cyclohexylidene)ethanol is commonly used in organic synthesis as a protecting group for alcohols, as the tert-butyldimethylsilyloxy groups can be easily removed under mild conditions to reveal the free hydroxyl group. Additionally, this compound has potential applications in the pharmaceutical industry and in the development of new materials due to its unique structure and reactivity.

Upstream product

• 139356-36-8 [(3R,5R)-3,5-bis-(tert-butyldimethylsilyloxy)cyclohexylidene]acetic acid ethyl ester 
• 208659-01-2 {2-[(3R,5R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-cyclohexylidene]-ethoxymethyl}-benzene 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 332097-70-8 ethyl ((3R,5R)-3,5-diacetoxy-cyclohexylidene)-acetate 
• 199613-48-4 5-tert-butyl-dimethylsilyloxy-(5S)-2-cyclohexenone 
• 357174-96-0 [(3R,5R)-3-(tert-Butyl-dimethyl-silanyloxy)-5-hydroxy-cyclohex-(Z)-ylidene]-acetic acid ethyl ester 
• 357174-93-7 [(1R,4R,6S)-4-(tert-butyldimethylsilyloxy)-7-oxa-bicyclo[4.1.0]hept-2-ylidene]acetic acid ethyl ester 
• 131245-86-8 (1R,3R)-1,3-diacetoxy-5-hydroxy-cyclohexane 
• 13314-30-2 cis-1,3,5-cyclohexane-triol 
• 332097-67-3 (3S,5S)-3,5-diacetoxy-cyclohexan-1-one 
• 208714-02-7 (1R,3R)-5-(2-Benzyloxy-ethylidene)-cyclohexane-1,3-diol 
• 208658-93-9 (R)-7-Benzyloxy-5-methylene-heptane-1,3-diol 
• 208658-83-7 (R)-7-Benzyloxy-3-(tert-butyl-dimethyl-silanyloxy)-5-methylene-heptanal 
• 208658-99-5 (R)-7-Benzyloxy-3-(tert-butyl-dimethyl-silanyloxy)-5-methylene-heptan-1-ol 

Downstream Products

• 139356-39-1 (1R,3R)-1,3-bis((tert-butyldimethyl)silanyloxy)-5-[2-(diphenylphosphinoyl)-ethylidene]cyclohexane 
• 241151-12-2 (1R,3R)-5-((2Z,9Z)-12,12,12-Trifluoro-11-hydroxy-7,7-dimethyl-11-trifluoromethyl-dodeca-2,9-dienylidene)-cyclohexane-1,3-diol 
• 241151-12-2 (1R,3R)-5-[(2E,9Z)-12,12,12-trifluoro-11-hydroxy-7,7-dimethyl-11-trifluoromethyl-dodeca-2,9-dienylidene]cyclohexane-1,3-diol 
• 130447-37-9 1α,25-dihydroxy-19-nor-vitamin D₃ 
• 139356-40-4 (1R,7aR)-4-[2-[(3R,5R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-cyclohexylidene]-eth-(E)-ylidene]-1-((R)-1,5-dimethyl-5-trimethylsilanyloxy-hexyl)-7a-methyl-octahydro-indene 
• 1451188-52-5 C₄₅H₇₈O₆SSi₂ 
• 1192803-39-6 C₃₉H₇₂O₃Si₂ 
• 1477494-91-9 C₃₉H₇₂O₃Si₂ 
• 1402710-05-7 C₂₀H₄₁IO₂Si₂ 
• 1263286-76-5 (1R,3R,7E,22E,24E)-24a-homo-19-nor-9,10-secoergosta-5,7,22,24-tetraen-1,3,25-triol 
• 1263286-72-1 (7E)-(1R,3R)-24-phenylsulfonyl-1,3-bis(tert-butyldimethylsililoxy)-9,10-seco-19,22,23-trinorchola-5,7-dien 
• 1263286-74-3 C₄₆H₇₆O₇SSi₂ 
• 1451188-49-0 C₄₀H₇₂O₃Si₂ 
• 1451188-50-3 C₄₂H₇₆O₃Si₂ 

Relevant articles and documents

Economical Process for Preparation of the 19-nor A Ring of Paricalcitol from (-)-Shikimic Acid

An economical and efficient means of preparing the 19-nor A ring, a key precursor of the vitamin D receptor (VDR) activator Paricalcitol, is here described. This process begins with commercially available (-)-shikimic acid and was easily scaled up to kilo

A new metabolite of Paricalcitol: stereoselective synthesis of (22Z)-isomer of 1α,25-dihydroxy-19-norvitamin D2

Stereoselective synthesis of (22Z)-isomer of Paricalcitol, an analog of 1,25-dihydroxyergocalciferol, an active form of vitamin D2 (Ergocalciferol) has been described. The two key critical synthetic steps involved are Julia–Lythgoe's Wittig–Hor

HYBRID MOLECULES HAVING MIXED VITAMIN D RECEPTOR AGONISM AND HISTONE DEACETYLASE INHIBITORY PROPERTIES

Hybrid molecules comprising a vitamin D receptor agonist moiety and an HDAC inhibitor moiety are described herein The HDAC inhibitor moiety can be modelled after an HDAC inhibitor selected from the group consisting of tπchostatm A, sodium butyrate, valpro